MA51914A - Formes posologiques et procédés pour obtenir du bupropion énantiomériquement enrichi ou pur - Google Patents
Formes posologiques et procédés pour obtenir du bupropion énantiomériquement enrichi ou purInfo
- Publication number
- MA51914A MA51914A MA051914A MA51914A MA51914A MA 51914 A MA51914 A MA 51914A MA 051914 A MA051914 A MA 051914A MA 51914 A MA51914 A MA 51914A MA 51914 A MA51914 A MA 51914A
- Authority
- MA
- Morocco
- Prior art keywords
- methods
- dosage forms
- enantiomerically enriched
- pure bupropion
- obtaining enantiomerically
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862634718P | 2018-02-23 | 2018-02-23 | |
US201962794469P | 2019-01-18 | 2019-01-18 | |
US201962809480P | 2019-02-22 | 2019-02-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA51914A true MA51914A (fr) | 2020-12-30 |
Family
ID=67688503
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA051914A MA51914A (fr) | 2018-02-23 | 2019-02-25 | Formes posologiques et procédés pour obtenir du bupropion énantiomériquement enrichi ou pur |
Country Status (19)
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL313368A (en) * | 2018-02-23 | 2024-08-01 | Axsome Therapeutics Inc | Dosage forms and methods for enantiomerically enriched or pure bupropion |
US11660273B2 (en) | 2018-09-20 | 2023-05-30 | Axsome Therapeutics, Inc. | Dosage forms and methods for enantiomerically enriched or pure bupropion |
US11291639B2 (en) | 2018-09-20 | 2022-04-05 | Axsome Therapeutics, Inc. | Dosage forms and methods for enantiomerically enriched or pure bupropion |
US11660274B2 (en) | 2018-09-20 | 2023-05-30 | Axsome Therapeutics, Inc. | Dosage forms and methods for enantiomerically enriched or pure bupropion |
WO2021055124A1 (en) * | 2019-09-20 | 2021-03-25 | Axsome Therapeutics, Inc. | Dosage forms and methods for enantiomerically enriched or pure bupropion |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2318960A1 (en) * | 1998-01-29 | 1999-08-05 | Sepracor Inc. | Pharmaceutical uses of optically pure (+)-bupropion |
US6337328B1 (en) * | 1999-03-01 | 2002-01-08 | Sepracor, Inc. | Bupropion metabolites and methods of use |
DE60330909D1 (de) * | 2003-08-08 | 2010-02-25 | Biovail Lab Int Srl | Tablette mit modifizierter freisetzung von bupropion hydrochlorid |
WO2012118562A1 (en) * | 2011-03-02 | 2012-09-07 | Rhine Pharmaceuticals, Llc | Compositions and methods for treating depression, adhd and other central nervous system disorders employing novel bupropion compounds, and methods for production and use of novel bupropion compounds and formulations |
US10080727B2 (en) * | 2013-11-05 | 2018-09-25 | Antecip Bioventures Ii Llc | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects |
US9474731B1 (en) * | 2013-11-05 | 2016-10-25 | Antecip Bioventures Ii Llc | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects |
US9198905B2 (en) * | 2013-11-05 | 2015-12-01 | Antecip Bioventures Ii Llc | Compositions and methods for reducing dextrorphan plasma levels and related pharmacodynamic effects |
WO2015095713A1 (en) * | 2013-12-20 | 2015-06-25 | Deuterx, Llc | Methods of treating neurological and other disorders using enantiopure deuterium-enriched bupropion |
IL313368A (en) * | 2018-02-23 | 2024-08-01 | Axsome Therapeutics Inc | Dosage forms and methods for enantiomerically enriched or pure bupropion |
-
2019
- 2019-02-25 IL IL313368A patent/IL313368A/en unknown
- 2019-02-25 BR BR112020017179-4A patent/BR112020017179A2/pt unknown
- 2019-02-25 CA CA3092076A patent/CA3092076A1/en active Pending
- 2019-02-25 PE PE2020001272A patent/PE20211752A1/es unknown
- 2019-02-25 KR KR1020237017449A patent/KR20230075531A/ko not_active Ceased
- 2019-02-25 MA MA051914A patent/MA51914A/fr unknown
- 2019-02-25 SG SG11202008056SA patent/SG11202008056SA/en unknown
- 2019-02-25 CR CR20200415A patent/CR20200415A/es unknown
- 2019-02-25 WO PCT/US2019/019445 patent/WO2019165379A1/en not_active Application Discontinuation
- 2019-02-25 MY MYPI2020004315A patent/MY202993A/en unknown
- 2019-02-25 KR KR1020247017593A patent/KR20240091043A/ko active Pending
- 2019-02-25 IL IL276871A patent/IL276871B2/en unknown
- 2019-02-25 EP EP19756920.5A patent/EP3755312A4/en active Pending
- 2019-02-25 KR KR1020207027256A patent/KR20210003091A/ko not_active Ceased
- 2019-02-25 JP JP2020544420A patent/JP2021513998A/ja active Pending
- 2019-02-25 NZ NZ767378A patent/NZ767378A/en unknown
- 2019-02-25 CN CN201980026874.5A patent/CN112087999A/zh active Pending
- 2019-02-25 AU AU2019223187A patent/AU2019223187B2/en active Active
- 2019-02-25 MX MX2020008704A patent/MX2020008704A/es unknown
-
2020
- 2020-08-20 MX MX2023009281A patent/MX2023009281A/es unknown
- 2020-08-21 NI NI202000056A patent/NI202000056A/es unknown
- 2020-08-21 CL CL2020002166A patent/CL2020002166A1/es unknown
- 2020-09-23 EC ECSENADI202060179A patent/ECSP20060179A/es unknown
-
2022
- 2022-06-27 AU AU2022204521A patent/AU2022204521B2/en active Active
- 2022-08-04 JP JP2022124557A patent/JP2022153638A/ja active Pending
-
2024
- 2024-03-15 JP JP2024041381A patent/JP2024075655A/ja active Pending
- 2024-08-17 AU AU2024205858A patent/AU2024205858A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CA3092076A1 (en) | 2019-08-29 |
KR20240091043A (ko) | 2024-06-21 |
IL276871A (en) | 2020-10-29 |
EP3755312A1 (en) | 2020-12-30 |
BR112020017179A2 (pt) | 2020-12-22 |
CR20200415A (es) | 2021-02-03 |
ECSP20060179A (es) | 2020-12-31 |
NZ767378A (en) | 2024-03-22 |
MX2023009281A (es) | 2023-08-17 |
MY202993A (en) | 2024-05-31 |
JP2024075655A (ja) | 2024-06-04 |
AU2022204521A1 (en) | 2022-07-21 |
CL2020002166A1 (es) | 2020-10-23 |
SG11202008056SA (en) | 2020-09-29 |
IL276871B1 (en) | 2024-07-01 |
KR20230075531A (ko) | 2023-05-31 |
JP2021513998A (ja) | 2021-06-03 |
AU2019223187A1 (en) | 2020-09-17 |
WO2019165379A1 (en) | 2019-08-29 |
AU2022204521B2 (en) | 2024-09-05 |
AU2024205858A1 (en) | 2024-09-05 |
IL313368A (en) | 2024-08-01 |
EP3755312A4 (en) | 2022-03-16 |
JP2022153638A (ja) | 2022-10-12 |
MX2020008704A (es) | 2020-12-07 |
CN112087999A (zh) | 2020-12-15 |
KR20210003091A (ko) | 2021-01-11 |
AU2019223187B2 (en) | 2022-07-28 |
NI202000056A (es) | 2021-01-11 |
PE20211752A1 (es) | 2021-09-06 |
IL276871B2 (en) | 2024-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA51914A (fr) | Formes posologiques et procédés pour obtenir du bupropion énantiomériquement enrichi ou pur | |
EP3987794A4 (en) | ENCODER, DECODER AND METHOD THEREOF | |
MA71705A (fr) | Substances et procédés pour le traitement d'hémoglobinopathies | |
EP3924159A4 (en) | Suction anchors and their methods of manufacture | |
EP3861743A4 (en) | VIDEO DECODER AND PROCESSES | |
EP3777138A4 (en) | VIDEO CODING METHODS AND APPARATUS | |
EP3552834A4 (en) | FRAME PLATE AND MANUFACTURING METHOD THEREOF | |
EP3532042A4 (en) | Methods for enhancing synaptogenesis and neuritogenesis | |
EP3864715A4 (en) | DISPLAY SUBSTRATE, DISPLAY APPARATUS AND METHOD OF MAKING DISPLAY SUBSTRATE | |
EP3556222C0 (en) | SYSTEM AND METHOD FOR PRODUCING A SUGAR STREAM | |
EP3791435A4 (en) | DISPLAY APPARATUS, AND DISPLAY SUBSTRATE AND METHOD OF MAKING IT | |
EP3982633A4 (en) | VIDEO ENCODER, VIDEO DECODER AND CORRESPONDING METHOD | |
EP3960868A4 (en) | Polyhydroxyalkanoic acid and method for producing same | |
EP3947406A4 (en) | SIALIDASE RESISTANT SACCHARIDE, METHOD FOR PRODUCTION AND USE | |
EP4026337A4 (en) | An encoder, a decoder and corresponding methods | |
EP3817382A4 (en) | VIDEO ENCODER, VIDEO DECODER AND CORRESPONDING METHOD | |
EP3781137A4 (en) | HUMIDITY RESISTANT PROBIOTIC GRANULE AND ITS PRODUCTION PROCESSES | |
EP3527191A4 (en) | COMPOSITE DENTAL RESIN MATERIAL, METHOD FOR PRODUCING COMPOSITE DENTAL RESIN MATERIAL, AND POLYARYLETHERCETONE RESIN FOR PRODUCING COMPOSITE DENTAL RESIN MATERIAL | |
EP3686306A4 (en) | SHEET STEEL, AND METHOD OF MANUFACTURING THE SAME | |
EP4076881C0 (de) | Vorrichtung zur herstellung von betonsteinen | |
EP3837845A4 (en) | VIDEO ENCODER, VIDEO DECODER AND CORRESPONDING PROCESSES | |
EP3896974A4 (en) | Video encoder, video decoder, and corresponding method | |
EP3777915A4 (en) | BLOOD PURIFICATION DEVICE AND ITS PRODUCTION PROCESS | |
EP3738940A4 (en) | MORTAR AND ITS MANUFACTURING PROCESS | |
EP3780103A4 (en) | IMAGING DEVICE AND ITS MANUFACTURING PROCESS |